Chl I LP Series Omics
Venture Capital FundFund ID 805-3202973713Delaware, United States
Gross assets
$75K
Min. investment
—
Beneficial owners
2
Size rank
Top 99%
Audited
No
Structure
Standalone
About this fund
Chl I LP Series Omics is a venture capital fund managed by Champion Hill Labs, LLC. The fund reports $75,000 in gross assets, placing it among the top 99% of private funds by size. Private funds are not required to publicly disclose returns; Form ADV reports assets, structure, and service providers, shown above.
Fund details
| Fund ID | 805-3202973713 |
| Fund type | Venture Capital Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | No |
| Annual audit | No |
| Prepared per GAAP | No |
| Sub-advised | No |
| Sales limited to qualified investors | No |
| % of assets independently valued | 0% |
Other funds from this manager
| Fund | Type | Gross assets |
|---|---|---|
| Chl Investor Fund, LLC | Venture Capital | $76.1M |
| Chl I LP Series and | Venture Capital | $66.6M |
| Ch Ventures II, L.P. | Venture Capital | $61.6M |
See all 25 funds from this manager — unlock the full record.
Join to unlock · $37/moFrequently asked questions
How large is Chl I LP Series Omics?
Chl I LP Series Omics reports $75,000 in gross assets, among the top 99% of private funds by size.
Who manages Chl I LP Series Omics?
Chl I LP Series Omics is managed by Champion Hill Labs, LLC.
Does Chl I LP Series Omics disclose returns?
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.
Manager
Service providers
How this fund compares
Gross assetsTop 99%
Larger than 1% of 67,041 private funds
Gross assets vs Venture Capital FundsTop 98%
Larger than 2% of 5,217 venture capital funds
Investor base
Adviser & related persons%
Funds of funds%
Non-U.S. persons33%
Share of the fund's beneficial ownership reported on Form ADV. Categories can overlap.